21610
GABA and Glutamate Concentrations in the Amygdala Modulate BOLD Response to Rapidly Presented Fearful-faces and Houses

Thursday, May 12, 2016: 11:30 AM-1:30 PM
Hall A (Baltimore Convention Center)
M. A. Reiter1, K. Kolodziej2, T. L. Richards2, N. M. Corrigan2, K. Sambrook1, T. St. John3, M. Reilly1, E. Shankland1, R. A. Edden4, S. Dager5 and N. M. Kleinhans2, (1)Radiology, University of Washington, Seattle, WA, (2)University of Washington, Seattle, WA, (3)University of Washington Autism Center, Seattle, WA, (4)Johns Hopkins University School of Medicine, Baltimore, MD, (5)University of Washington School of Medicine, Seattle, WA
Background:  

Abnormal face-processing is a pervasive deficit in individuals with ASD, which may be driven by amygdala dysfunction. Although the relationship between atypical functional and structural characteristics of the amygdala and abnormal face processing has been widely reported in ASD, the role of biochemical characteristics is largely unknown.  Both glutamatergic and GABAergic mechanisms are thought to underlie experience-dependent plasticity of neural circuits, including those involved in emotional face processing. However little is known about the role of GABA and Glutamate (Glu) in modulating the BOLD response to fearful-faces and objects in humans.

Objectives:  

Investigate the relationship between GABA and Glu concentrations in the amygdala and BOLD response to fearful-faces and houses in a sample of children with ASD and other sensory difficulties.  

Methods:  

T1-weighted 3DMPRAGE, fMRI, and magnetic resonance spectroscopic (MRS) data were acquired on a 3T Philips Achieva. Data were collected for 17 individuals and after quality control 14 were included in the analysis (mean age:10.4(1.64), IQ: 123.5(19.9)).

Data acquisition, fMRI:  54 volumes of high resolution data (2.3mm3) were collected. Participants were shown blocks of rapidly-presented fearful-faces, houses and scrambled images. MRS: Single-voxel MRS data were acquired from the left amygdala-hippocampal region at two echo times (TE=30 and 80ms) using a MEGA-PRESS pulse sequence (TR 2000, 2048 complex time points, spectral width 2000 Hz, 32 averages, voxel size 30x30x30mm). A similar sequence, with a modification for GABA-editing, was acquired from the same voxel location (TR/TE 2000/68ms).

Data processing: fMRI data were processed using FSL. MRS: The LCModel software package (Provencher, 1993), with water-signal referencing, was used to derive concentration estimates for Creatine and Glu. The GABA-edited data were processed using the “Gannet” software toolkit.

Analysis: FMRI analyses were conducted using FLAME. Concentrations of GABA and Glu were entered as covariates in the GLM to test the correlation between chemical concentration and activation to fearful-faces and houses. Data were corrected for multiple comparisons using cluster-thresholding set at z>2.3 (voxel height) and p<.05 (cluster extent), whole brain corrected.

Results:  

Fearful-faces: Higher concentrations of amygdala GABA were associated with decreased activation to fearful-faces in the amygdala. Amygdala Glu concentration was positively correlated to activation in the prefrontal cortex, superior parietal lobule, lateral occipital cortex, and cerebellar vermis and negatively correlated to activation in the striatum and subcallosal cortex.

Houses: Higher concentrations of amygdala GABA were associated with increased activation to houses in the prefrontal cortex, and with decreased activation in the hippocampus and fusiform gyrus. Higher concentrations of Glu were associated with increased activation to houses in the frontal-pole and frontal eye fields. 

Conclusions:  

Higher levels of Glu were associated with widespread increases in cortical activation to both fearful-faces and houses. Higher amygdala GABA levels were specifically associated with decreased activation to fearful-faces in emotional face-processing areas, and with decreased activation to houses in areas involved in object-processing and memory. This suggests that interactions between GABA and Glutamatergic mechanisms within the amygdala may underlie some of the emotional face-processing deficits experienced by individuals with ASD.